Fig. 6From: Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithmComparison between the sum of diameters (SOD), derived by the personalization algorithm, and the value measured from imaging assessments, at each clinically measured time point, for all patients, presented on a normal scale (a), and on a log scale (b). The reference line marks equality between the fitted and predicted SOD values. Values of 0 were excluded from the dataset for calculation of R-squaredBack to article page